2
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Polycystic Ovary Syndrome
3
Fatty Liver
2
Diabetes Mellitus
2
Thyroid Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Obesity
1
Neoplasms
1
Menstruation Disturbances
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma
1
Iron Overload
1
Hypertriglyceridemia
1
Hyperthyroidism
1
Hemoglobinopathies
1
Graves Disease
1
Glucose Metabolism Disorders
1
Glucose Intolerance
1
Fibrous Dysplasia, Polyostotic
1
Fibrous Dysplasia of Bone
1
Interventions
Deferasirox
2
Magnetic Resonance Spectroscopy
1
Glucose Tolerance Test
1
Deferoxamine
1
Continuous Glucose Monitoring
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Iron Overload
×
Glucose Tolerance Test
×
Clear all
NCT03141398
2017-07-26
CGMs
Hamad Medical Corporation
Withdrawn